Because of the overwhelming interest in using Viedoc for Covid-19 vaccine research, Viedoc Technologies is continuing its offer of free Viedoc licenses until the end of August. The need for the ability to quickly set-up studies in the global race for a vaccine shows how important this is.
Thousands of lives can be saved, and the economic impact of returning to normal is boundless. For these reasons, Viedoc Technologies decided to offer free Viedoc licenses in Covid-19 vaccine studies. Since we first went out with this offer, we have been amazed by the increased interest in Viedoc. Thousands of people on social media and from companies around the world have expressed their enthusiasm by supporting us in this idea.
After only a few weeks, several studies have been set up and have already started recruiting patients. Some studies were up and running within three weeks! Many more studies are in the development stage in the rush to discover a vaccine. Viedoc Technologies is proud to be able to help our clients deliver within these extremely compressed timelines.
However, the struggle to find a vaccine continues. That's why Viedoc Technologies is extending its offer until the end of August. We continue to support those working to end the current situation as quickly as possible—and to help make the world a healthier place.
To find out how you can initiate your study in Viedoc, email us at .
"Viedoc is an easy-to-use platform made even better with great customer service"